U.S. RESEARCH ROUNDUP-Apollo, Phillips 66, Valero Energy
U.S. RESEARCH ROUNDUP- Analog Devices, Crowdstrike, Deere & Co
Brief: Avalyn Announces Additional Long-Term Data On Ap01, Inhaled Pirfenidone, For The Treatment Of Pulmonary Fibrosis
NASDAQ RESUMED AT 12:23 PM
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM
Brief: Avalyn Announces Pricing Of Upsized Initial Public Offering
Brief: Avalyn Pharma Now Sees IPO Of 16.7 Million Shares Of Common Stock - SEC Filing
Brief: Avalyn Strengthens Leadership Team To Support Long-Term Growth With Appointments Of Industry Leaders Adam Golden And Frank Salisbury
Brief: Avalyn Pharma Inc Announces IPO Of 11,800,000 Shares Of Common Stock